Alpha Layer / Signal Explorer

Signal Explorer

10-K · 10-Q · 8-K · last 6 months · ← back to feed

Clear ×
Glucotrack, Inc. GCTK

Showing 10-K, 10-Q & 8-K from the last 6 months. Need full history or all form types?

Apr 14, 2026 8-K 3 signals fired
Other
Amendment Modification Waiver Clause Corporate Authority Representation Non Assignment Clause
Mar 30, 2026 10-K 76 signals fired · top 15
Other
Auditor Appointment Ratification Warrant Valued Black Scholes Net Loss Reported Codm Segment Reporting Disclosure Reverse Stock Split Effected Ipo Or Capital Raising Completion Other Income Expense Disclosure Incorporation Or Reincorporation Disclosure Material Weakness In Internal Controls Disclosed Depreciation Expense Composition Disclosure Headcount Disclosure Standard Nol Tax Credit Carryforward Nol Carryforward Expiration Disclosure Market Volatility Risk Disclosure Amendment Modification Waiver Clause
Mar 27, 2026 8-K 10 signals fired
Other
Patent Family Portfolio Disclosure Interim Data Positive Enrollment Ahead Of Schedule First Patient Treated Protocol Amended Publication Positive
Core
Clinical Trial Result Clinical Hold Lead Asset Progress Indication Expansion
Mar 13, 2026 8-K 2 signals fired
Other
Quorum Presence Disclosed Warrant Valued Black Scholes
Jan 29, 2026 8-K 1 signal fired
Other
Patent Family Portfolio Disclosure
Dec 31, 2025 8-K 31 signals fired · top 15
Other
Warrant Valued Black Scholes Use Of Proceeds Disclosure Fcpa Compliance Representation Closing Deliverables Specified New York Jurisdiction Clause No Broker Fees Representation Amendment Modification Waiver Clause Non Assignment Clause Market Price Definition No Regulatory Approval Required Institutional Investment Investment Company Act Exemption Claimed Material Weakness Internal Controls Ipo Net Proceeds Disclosure Regulation D Offering Disclosure
Dec 29, 2025 8-K 0 signals fired
No signals above threshold for this filing.
Nov 13, 2025 10-Q 26 signals fired · top 15
Other
Warrant Valued Black Scholes Codm Segment Reporting Disclosure Ipo Net Proceeds Disclosure Net Loss Reported Ipo Or Capital Raising Completion Segment Aggregation Disclosure Other Income Expense Disclosure Institutional Investment Advertising Cost Disclosure Protocol Amended Personnel Cost Decrease Disclosure Convertible Debt Conversion Administrative Efficiency Share Repurchase Activity Disclosed Shares Outstanding Disclosure
Nov 13, 2025 8-K 6 signals fired
Other
Net Loss Reported Liquidity Position Snapshot Disclosed Quarterly Performance Praise Financing Activities Cash Flow Disclosure
Core
Indication Expansion Clinical Hold
Nov 7, 2025 8-K 1 signal fired
Other
Quorum Presence Disclosed
Nov 6, 2025 8-K 2 signals fired
Other
Adjournment Proposal Voting Requirement Quorum Presence Disclosed
Oct 29, 2025 8-K 3 signals fired
Other
Board Committee Member Listing Executive Educational Background Disclosure Kol Endorsement